Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. reports on the minutes of the Board of Directors meeting held on March 30, 2026. The filing covers corporate governance actions, including the approval of net income allocation for the fiscal year ended December 31, 2025, management compensation limits for 2026, bylaw amendments, and a capital increase resulting from stock option exercises. The company is scheduled to hold its Annual Ordinary and Extraordinary Shareholders' Meetings on April 30, 2026.
Key Financial Metrics
- Fiscal Year 2025 Net Profit: R$ 15,503,399,889.90
- Interest on Own Capital (2025): R$ 10,903,280,319.95 (gross)
- Investments Reserve Allocation (2025): R$ 6,854,843,618.36
- Tax Incentives Reserve Allocation (2025): R$ 228,202,821.12
- Capital Stock (Post-Increase): R$ 58,308,213,544.96
- Total Shares Outstanding: 15,763,664,889 registered common shares
- 2026 Management Compensation Cap: R$ 162,176,731.00 (Managers) and R$ 2,471,314.00 (Fiscal Council)
Material Changes vs. Prior Period
- Capital Increase: The company issued 2,026,133 new common shares on March 30, 2026, raising R$ 33,127,274.55. This increased the capital stock from R$ 58,275,086,270.41 to R$ 58,308,213,544.96.
- Re-ratification of 2024 Allocations: The Board re-ratified amounts allocated to reserves for the fiscal year 2024. The Investment Reserve was adjusted from R$ 10,339,054,767.31 to R$ 10,194,417,186.13, and the Tax Incentive Reserve was adjusted from R$ 108,125,431.35 to R$ 252,763,012.53.
- Bylaw Amendments: Proposed amendments include clarifying that interim dividends and interest on capital are only considered advance payments of the mandatory minimum dividend unless the Board resolves otherwise.
Guidance, Outlook, and Management Commentary
The filing does not provide specific revenue guidance, profit forecasts, or liquidity outlook for the current or future periods. Management commentary is limited to the approval of the 2025 financial results and the setting of compensation caps for 2026. The filing notes that the 2025 financial statements and management report were published on February 12, 2026, and are available on the company's Investor Relations website and the CVM system.
Risks and Contingencies: The filing does not explicitly detail new material risks or contingencies beyond standard corporate governance procedures. The re-ratification of 2024 reserves suggests adjustments were necessary based on final accounting determinations.
Investor Verification Checklist
- Verify the final approved allocation of the R$ 15.5 billion net profit for 2025 at the April 30, 2026 Shareholders' Meeting.
- Confirm the impact of the R$ 33.1 million capital increase on earnings per share and ownership dilution.
- Review the full text of the proposed bylaw amendments regarding dividend policies and executive officer frameworks.
- Check the detailed breakdown of the R$ 6.85 billion allocated to the Investments Reserve, specifically the R$ 2.38 billion related to IAS 29/CPC 42 (hyperinflation) effects.
- Monitor the election results for the Board of Directors and Fiscal Council at the upcoming meeting.